News
Boehringer Ingelheim partners with Science 37 for virtual clinical trials
Boehringer Ingelheim collaborates with Science 37 to accelerate the clinical development of new therapies worldwide; Science 37’s technology enables patients to remotely participate in clinical studies
Alphabet’s Verily raises 1 billion dollar investment to fund growth and innovation
The capital raised will support growth in key strategic areas, including investments in strategic partnerships, global business development opportunities, and potential acquisitions.
